Biomarker-Based Methods for Determining Noncompliance in a Prevention Trial

    December 2002 in “ Controlled Clinical Trials
    Donna K. Pauler, Kathryn B. Gower, Phyllis J. Goodman, John J. Crowley, Ian M. Thompson
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study suggests that simple absolute threshold monitoring rules for compliance using the biomarker DHT perform similarly to more complex methods in the Prostate Cancer Prevention Trial.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results